The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Placing to Raise £2.76 Million

26 Nov 2018 14:00

RNS Number : 5181I
Location Sciences Group PLC
26 November 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL ("RESTRICTED JURISDICTIONS"). THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY

Prior to publication, this announcement contained inside information within the meaning of Article 7 of the EU Market Abuse Regulation 596/2014. With the publication of this announcement, this information is now considered to be in the public domain

26 November 2018

Location Sciences Group PLC

("Location Sciences" or the "Company")

COMPLETION OF PLACING TO RAISE £2.76 MILLION

Location Sciences Group PLC (AIM: LSAI), the leading mobile location data and intelligence expert, is pleased to announce that it has raised approximately £2.76 million (gross) through a placing of 122,822,221 new ordinary shares of 1 pence each ("Placing Shares") in the share capital of the Company (the "Placing") at a price of 2.25 pence per Placing Share (the "Issue Price"). The Company also provides further detail on the Open Offer announced earlier today.

The Placing Shares being issued represent approximately 58.5 per cent. of the Company's existing issued share capital prior to the Placing. The Issue Price represents a discount of 10 per cent. to the closing mid-market price of 2.5 pence per Existing Ordinary Share on 23 November 2018 (being the last Business Day prior to the announcement of the Placing and Open Offer released earlier today). Stockdale Securities Limited is acting as Nominated Adviser and Broker to the Company in connection with the Placing.

Directors' participations

David Rae, Chief Financial Officer of the Company, has subscribed for 666,667 Placing Shares at the Issue Price as part of the Placing. Following Admission, Mr Rae will hold 1,166,667 Ordinary Shares in the Company representing approximately 0.35 per cent. of the Enlarged Share Capital.

In recognition of his service to the Company, and in order to incentivise him and further align his interests to those of the Company's shareholders, the Board has agreed to award Mark Slade, Chief Executive Officer of the Company, a cash bonus to match the level of his personal investment in the Placing of £50,000, on condition that the proceeds of this bonus are invested in the Placing. As such, Mark Slade has subscribed for 4,444,444 Placing Shares at the Issue Price as part of the Placing. Following Admission, Mark Slade will hold 6,204,444 Ordinary Shares in the Company representing approximately 1.87 per cent. of the Enlarged Share Capital.

Admission and total voting rights

Application has been made to the London Stock Exchange for the admission of the Placing Shares to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on 29 November 2018. The Placing Shares will, on Admission, rank pari passu with the Existing Ordinary Shares. Following Admission, the Enlarged Share Capital will comprise 332,655,659 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Mark Slade, Chief Executive, of Location Sciences, commented: "We are delighted to announce the successful completion of the Placing. This is a significant milestone in the turnaround of Location Sciences and, although there is still a huge amount of work to do, we now have the working capital in place to fulfil the Board's plans for the next stage of growth. I would like to take this opportunity to thank all of our shareholders, both new and old, for their support and faith in our vision for the business. As a management team we are fully aligned with their goals and we look to the future with confidence."

The Open Offer

In order to provide Shareholders who have not taken part in the Placing with an opportunity to participate, the Company is providing all Qualifying Shareholders with the opportunity to subscribe for an aggregate of up to 20,983,344 Ordinary Shares, to raise up to approximately £0.47 million (before expenses), on the basis of 1 new Ordinary Share for every 10 Existing Ordinary Shares held on the Record Date, at the Issue Price, payable in full at the time of acceptance of the Open Offer. Any Open Offer Shares not subscribed for by Qualifying Shareholders will be available to Qualifying Shareholders under the Excess Application Facility.

The Open Offer provides Qualifying Shareholders with an opportunity to participate in the proposed issue of New Ordinary Shares whilst providing the Company with additional capital to invest in the business of the Group.

The Issue Price is the same for the Open Offer and the Firm Placing and represents a discount of 10 per cent. to the closing mid-market price of 2.5 pence per Existing Ordinary Share on 23 November 2018 (being the last Business Day prior to the announcement of the Placing and Open Offer).

The Open Offer is conditional on the Placing becoming or being declared unconditional in all respects and not being terminated prior to admission of the Open Offer Shares to trading on AIM ("Open Offer Admission"). The principal conditions to the Open Offer are:

(a) the Placing Agreement having become unconditional and not having been terminated in accordance with its terms prior to Admission; and

(b) Open Offer Admission becoming effective by no later than 8.00 a.m. on 14 December 2018 or such later time and/or date (being no later than midday on 31 December 2018) as Stockdale Securities and the Company may agree.

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

Record Date for entitlements under the Open Offer

close of business on23 November 2018

Announcement of the Placing and Open Offer

7.00 a.m. on 26 November 2018

Publication and posting of the Open Offer Circular and the Application Form

27 November 2018

Ex-entitlement Date for the Open Offer

8.00 a.m. on 27 November 2018

Open Offer Entitlements and Excess CREST Open Offer Entitlements credited to stock accounts of Qualifying CREST Shareholders in CREST

as soon as practical after8.00 a.m. on 28 November 2018

Placing Admission and commencement of dealings in the Placing Shares on AIM

8.00 a.m. on 29 November 2018

Recommended latest time and date for requesting withdrawal of Open Offer Entitlements and Excess CREST Open Offer Entitlements from CREST

4.30 p.m. on 5 December 2018

Recommended latest time for depositing Open Offer Entitlements and Excess CREST Open Offer Entitlements into CREST

3.00 p.m. on 6 December 2018

Latest time and date for splitting Application Forms (to satisfy bona fide market claims only)

3.00 p.m. on 11 December 2018

Latest time and date for receipt of completed Application Forms and appropriate payment in respect of Open Offer Shares or Excess Shares or settlement of relevant CREST instruction

10.00 a.m. on13 December 2018

Announcement of result of Open Offer

7.00 a.m. on 14 December 2018

Open Offer Admission and commencement of dealings in the Open Offer Shares on AIM

8.00 a.m. on 14 December 2018

CREST members' accounts credited in respect of Open Offer Shares in uncertificated form

by 8.00 a.m. on14 December 2018

Despatch of definitive share certificates for Open Offer Shares in certificated form

by no later than 28 December 2018

A circular (the "Open Offer Circular") will be posted tomorrow to Qualifying Shareholders setting out further details of the Open Offer and the full terms and conditions on which it is being made, including the procedure for application and payment. A copy of the Open Offer Circular will be available on the Company's website at: https://www.locationsciences.ai/.

Save as defined herein, capitalised terms used in this announcement have the same meaning as in the Open Offer Circular.

For further information please contact:

Location Sciences Group PLC

Via Newgate Communications

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

Stockdale Securities Limited

Tel: +44 (0)20 7601 6100

Tom Griffiths

 

Ed Thomas

 

 

 

 

Newgate Communications

 

Tel: +44 (0)20 3757 6880

Bob Huxford

 

Fiona Norman

 

 

About Location Sciences Group PLC:

 

Location Sciences helps companies connect the online world with the offline world using mobile location technology data. We combine cutting-edge mobile location data collection with proprietary machine learning analytics to create new value and insights from location information.

 

Location Sciences is media-agnostic and works with a variety of media, advertising and technology partners - plus the world's biggest brands. Our technology is well positioned to fulfil the need for greater accuracy and accountability in a growing market that is increasingly looking for superior data and verification.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIFKADPNBDDADB
Date   Source Headline
1st Jun 20207:00 amRNSIssue of Equity and Total Voting Rights
11th May 20201:51 pmRNSHolding(s) in Company
11th May 20201:50 pmRNSHolding(s) in Company
7th May 20202:06 pmRNSSecond Price Monitoring Extn
7th May 20202:00 pmRNSPrice Monitoring Extension
6th May 202010:42 amRNSIssue of Equity and Total Voting Rights
1st May 20202:06 pmRNSSecond Price Monitoring Extn
1st May 20202:00 pmRNSPrice Monitoring Extension
29th Apr 202011:06 amRNSSecond Price Monitoring Extn
29th Apr 202011:01 amRNSPrice Monitoring Extension
20th Apr 20203:16 pmRNSIssue of Equity and Total Voting Rights
9th Apr 202012:17 pmRNSResult of AGM
9th Apr 20207:00 amRNSAGM statement
8th Apr 202010:11 amRNSHolding(s) in Company
3rd Apr 20202:06 pmRNSHolding(s) in Company
3rd Apr 20207:00 amRNSAttendance at the Company’s AGM
1st Apr 20204:45 pmRNSHolding(s) in Company
31st Mar 202010:12 amRNSHolding(s) in Company
31st Mar 202010:10 amRNSHolding(s) in Company
26th Mar 202011:50 amRNSResult of GM, Appointment of Joint Broker and TVR
26th Mar 20207:00 amRNSIssue of Warrants
23rd Mar 202012:00 pmRNSCovid-19 Update
16th Mar 20203:33 pmRNSNotice of GM
16th Mar 20207:00 amRNSAnnual Financial Report
6th Mar 20204:04 pmRNSConditional Placing and Share Re-organisation
3rd Mar 20207:00 amRNSGlobal Master Service Agreement and Partnership
28th Feb 20202:05 pmRNSSecond Price Monitoring Extn
28th Feb 20202:00 pmRNSPrice Monitoring Extension
26th Feb 20202:51 pmRNSStatement Regarding Share Price Movement
24th Jan 202010:09 amRNSHolding(s) in Company
23rd Jan 20207:00 amRNSReport: The State of Privacy & Location Marketing
20th Jan 202011:41 amRNSIssue of Equity and Total Voting Rights
15th Jan 20202:00 pmRNSTrading Update and Partnership with X-Mode
17th Dec 20199:00 amRNSHolding(s) in Company
17th Dec 20198:56 amRNSHolding(s) in Company
12th Nov 20192:45 pmRNSMello London 2019 Presentation
28th Oct 201911:00 amRNSLocation Sciences to present at Mello London 2019
28th Oct 20198:57 amRNSLocation Sciences to present at Mello London 2019
7th Oct 20194:12 pmRNSHolding(s) in Company
7th Oct 20194:09 pmRNSHolding(s) in Company
27th Sep 201911:18 amRNSResult of Placing
26th Sep 20196:24 pmRNSUpdate re Placing
26th Sep 20197:01 amRNSProposed Placing
26th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSContract with Vicinity Media
5th Sep 20197:00 amRNSPartnership with Blis
2nd Sep 20199:29 amRNSAdvisory Panel Appointment
1st Aug 20198:31 amRNSTrading Update and Appointment
15th Jul 20197:00 amRNSLocation Sciences appoints Andy Roberts
24th Jun 20191:38 pmRNSDirector's Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.